Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Christopher Jones

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
JAMA Oncology|June 2, 2022
Association of Daratumumab Use With Ocular Events in a Case Series of US AdultsMichelle Nadeau Nguyen, Wiley Chambers, Graça M Dores, et al.
Annals of Internal Medicine|November 22, 2017
Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C VirusSusan J Bersoff-Matcha, Kelly Cao, Mihaela Jason, et al.
JACC. Cardiooncology|August 16, 2021
Cisplatin-Associated Aortic Thrombosis: A Review of Cases Reported to the FDA Adverse Event Reporting SystemMichelle C Nadeau Nguyen, Daniel Woronow, Bailee Binks, et al.
Drug Safety|January 26, 2020
An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting SystemKathryn Marwitz, S Christopher Jones, Cindy M Kortepeter, et al.
Journal of the American Medical Informatics Association : JAMIA|October 17, 2023
Using natural language processing to characterize and predict homeopathic product-associated adverse events in consumer reviews: comparison to reports to FDA Adverse Event Reporting System (FAERS)Karen Konkel, Nurettin Oner, Abdulaziz Ahmed, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|November 25, 2015
Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting SystemS Christopher Jones, Debra L Ryan, Valerie S W Pratt, et al.
American Journal of Hematology|April 16, 2020
Proteasome inhibitor-associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literatureMichelle Nadeau Nguyen, Afrouz Nayernama, S Christopher Jones, et al.
Annals of Internal Medicine|April 25, 2017
Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting SystemSusan J Bersoff-Matcha, Kelly Cao, Mihaela Jason, et al.
The Journal of Infection|November 9, 2018
Unusual Neisseria species as a cause of infection in patients taking eculizumabPage E Crew, Lucy McNamara, Peter E Waldron, et al.
The Journal of Infection|November 30, 2019
Antibiotic prophylaxis in vaccinated eculizumab recipients who developed meningococcal diseasePage E Crew, Lucy McNamara, Peter E Waldron, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
JAMA Oncology|June 2, 2022
Association of Daratumumab Use With Ocular Events in a Case Series of US AdultsMichelle Nadeau Nguyen, Wiley Chambers, Graça M Dores, et al.
Annals of Internal Medicine|November 22, 2017
Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C VirusSusan J Bersoff-Matcha, Kelly Cao, Mihaela Jason, et al.
JACC. Cardiooncology|August 16, 2021
Cisplatin-Associated Aortic Thrombosis: A Review of Cases Reported to the FDA Adverse Event Reporting SystemMichelle C Nadeau Nguyen, Daniel Woronow, Bailee Binks, et al.
Drug Safety|January 26, 2020
An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting SystemKathryn Marwitz, S Christopher Jones, Cindy M Kortepeter, et al.
Journal of the American Medical Informatics Association : JAMIA|October 17, 2023
Using natural language processing to characterize and predict homeopathic product-associated adverse events in consumer reviews: comparison to reports to FDA Adverse Event Reporting System (FAERS)Karen Konkel, Nurettin Oner, Abdulaziz Ahmed, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|November 25, 2015
Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting SystemS Christopher Jones, Debra L Ryan, Valerie S W Pratt, et al.
American Journal of Hematology|April 16, 2020
Proteasome inhibitor-associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literatureMichelle Nadeau Nguyen, Afrouz Nayernama, S Christopher Jones, et al.
Annals of Internal Medicine|April 25, 2017
Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting SystemSusan J Bersoff-Matcha, Kelly Cao, Mihaela Jason, et al.
The Journal of Infection|November 9, 2018
Unusual Neisseria species as a cause of infection in patients taking eculizumabPage E Crew, Lucy McNamara, Peter E Waldron, et al.
The Journal of Infection|November 30, 2019
Antibiotic prophylaxis in vaccinated eculizumab recipients who developed meningococcal diseasePage E Crew, Lucy McNamara, Peter E Waldron, et al.
Pageof 4